Abnormal feeding behavior and insulin replacement in STZ-induced diabetic rats. 1990

Y Shimomura, and M Takahashi, and H Shimizu, and N Sato, and Y Uehara, and M Negishi, and T Inukai, and I Kobayashi, and S Kobayashi
Department of Medicine, Gunma University of Medicine, Maebashi, Japan.

The present studies were undertaken to investigate whether or not decreased ambulatory activity, including abnormal feeding behavior in diabetic rats, will be simultaneously normalized by insulin administration. To do this, we used the Gunma University-type automatic apparatus for continuous and direct measurement of ambulation and drinking. In this study, 3 U NPH insulin were administered at 1800, just before the dark phase, and 2 U were administered at 0600, just before the light phase. With these insulin doses, we found that 5 weeks were needed to normalize ambulatory activity, 4 weeks were necessary for food intake, 6 weeks for drinking and 2 weeks for body weight. Since ambulatory activity is reported to be related to changes in dopamine turnover, further studies are in progress to determine whether or not dopamine turnover is normalized when there is no difference in ambulatory activity due to insulin replacement.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007336 Insulin, Isophane An intermediate-acting INSULIN preparation with onset time of 2 hours and duration of 24 hours. It is produced by crystallizing ZINC-insulin-PROTAMINES at neutral pH 7. Thus it is called neutral protamine Hagedorn for inventor Hans Christian Hagedorn. Insulin, NPH,Insulin, Protamine Zinc,Isophane Insulin, Regular,NPH Insulin,Neutral Protamine Hagedorn Insulin,Protamine Hagedorn Insulin,Hagedorn Insulin, Protamine,Isophane Insulin,Protamine Zinc Insulin,Regular Isophane Insulin,Zinc Insulin, Protamine
D008297 Male Males
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D011954 Receptors, Dopamine Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells. Dopamine Receptors,Dopamine Receptor,Receptor, Dopamine
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D003921 Diabetes Mellitus, Experimental Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY. Alloxan Diabetes,Streptozocin Diabetes,Streptozotocin Diabetes,Experimental Diabetes Mellitus,Diabete, Streptozocin,Diabetes, Alloxan,Diabetes, Streptozocin,Diabetes, Streptozotocin,Streptozocin Diabete
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine

Related Publications

Y Shimomura, and M Takahashi, and H Shimizu, and N Sato, and Y Uehara, and M Negishi, and T Inukai, and I Kobayashi, and S Kobayashi
July 1992, Diabetes,
Y Shimomura, and M Takahashi, and H Shimizu, and N Sato, and Y Uehara, and M Negishi, and T Inukai, and I Kobayashi, and S Kobayashi
March 2013, Journal of the renin-angiotensin-aldosterone system : JRAAS,
Y Shimomura, and M Takahashi, and H Shimizu, and N Sato, and Y Uehara, and M Negishi, and T Inukai, and I Kobayashi, and S Kobayashi
April 1993, Diabetes,
Y Shimomura, and M Takahashi, and H Shimizu, and N Sato, and Y Uehara, and M Negishi, and T Inukai, and I Kobayashi, and S Kobayashi
November 2016, Pharmaceutical biology,
Y Shimomura, and M Takahashi, and H Shimizu, and N Sato, and Y Uehara, and M Negishi, and T Inukai, and I Kobayashi, and S Kobayashi
September 2008, The Journal of steroid biochemistry and molecular biology,
Y Shimomura, and M Takahashi, and H Shimizu, and N Sato, and Y Uehara, and M Negishi, and T Inukai, and I Kobayashi, and S Kobayashi
October 1993, Diabetes,
Y Shimomura, and M Takahashi, and H Shimizu, and N Sato, and Y Uehara, and M Negishi, and T Inukai, and I Kobayashi, and S Kobayashi
January 1993, Diabetes,
Y Shimomura, and M Takahashi, and H Shimizu, and N Sato, and Y Uehara, and M Negishi, and T Inukai, and I Kobayashi, and S Kobayashi
January 1995, Diabetes research and clinical practice,
Y Shimomura, and M Takahashi, and H Shimizu, and N Sato, and Y Uehara, and M Negishi, and T Inukai, and I Kobayashi, and S Kobayashi
September 2023, Applied biochemistry and biotechnology,
Y Shimomura, and M Takahashi, and H Shimizu, and N Sato, and Y Uehara, and M Negishi, and T Inukai, and I Kobayashi, and S Kobayashi
October 2000, Gene therapy,
Copied contents to your clipboard!